M A Hashmi1, Shyam Baboo2, Bibhuti Saha3. 1. Medical College and Hospitals Campus, MRI Section, Muzaffarpur, Bihar, India. 2. Department of Radiology, SKMCH, Muzaffarpur, Bihar, India. 3. Department of Medicine, School of Tropical Medicine, Kolkata, West Bengal, India.
Sir,Human deficiency virus (HIV) causes acquired immune deficiency syndrome (AIDS). The immune system of the body is vulnerable to attack by this virus and leads to multiple focal and diffuse lesions. Reduction in CD4 cells is seen. CD4 cells are type of immune cells, and they are also called “T-cells” or “helper cells.” Centers for Disease Control and Prevention define a person having AIDS if they have a CD4 count below 200, with or without any opportunistic infections or cancers.[1] Patients were mainly from School of tropical Medicine the largest tertiary center in eastern India, and from Medical College and Hospitals. Altogether 32 patients who were seropositive for HIV were examined in our center. Detailed history covering all relevant points including CD4 count and CD4% was recorded. Magnetic resonance (MR) spectroscopy study was done in all patients putting the voxel in white matter area. The study was done at 1.5 Tesla GE Signa, and the results were compiled and data analyzed.The data were accumulated in a tabular form as shown in Table 1 and Table 2. The majority of the patients were males about, and they were about 67.75% of the total population. Most of the patients were in the age group of 20–40 years and they comprised 93.75% of our study group. Twenty-four patients had CD4 count <200 cells/mm3. Eight patients had CD4 count above 200 cells/mm3. CD4% below 5% was seen in 9 patients comprising about 28.0%. CD4% between 5% and 10% was seen in 10 patients comprising about 31.25%. Six patients had CD4% between 20% and 40%. White matter changes were seen in 18 patients comprising about 56% of the study population as shown in Figure 1. MR Spectroscopy showing choline peaks which was seen in 16 patients [voxel placed as seen in Figures 2 and 3 is showing choline peaks] who were having white matter changes and comprised about 89% of them. The finding was that absolute risk of having white matter lesions in AIDspatient was 56.25%. Absolute Risk of choline peaks in patients with white matter lesions was 89.20%. Absolute risk of choline peaks in patients with CD4 Count below 200 was 58.33%.
Table 1
Number of persons with CD4 count less and more than 200/mm3 and with choline peaks
Table 2
The percentage and absolute risk in different group
Figure 1
T2 fluid-attenuated inversion recovery images are showing small white matter hyperintensities in the right subcortical parietal region and in periventricular region
Figure 2
Magnetic resonance spectroscopy done in posterior periventricular lesion
Figure 3
Magnetic resonance spectroscopy showed increase in choline peaks at that level
Number of persons with CD4 count less and more than 200/mm3 and with choline peaksThe percentage and absolute risk in different groupT2 fluid-attenuated inversion recovery images are showing small white matter hyperintensities in the right subcortical parietal region and in periventricular regionMagnetic resonance spectroscopy done in posterior periventricular lesionMagnetic resonance spectroscopy showed increase in choline peaks at that levelHIV infection leads to multiple and diffuse lesions in the brain. Noninfective and nonmitotic focal lesions can also be small or diffuse white matter changes. CD4 cells are type of white cells that fight infection. CD4 cells move throughout the body destroying germ cells such as bacteria and viruses. A normal CD4 count is from 500 to 1500 cells cubic millimeter. Some patients can have CD4 countless but not so severe infections while the reverse can also be seen. CD4% or the rate of its change is a better predictor of clinical progression. Although the CD4+ absolute number that identifies a specific level of immune suppression changes with age,[2] the CD4+ percentage that defines each immunologic category does not. Thus, a change in CD4+ percentage, not number, may be a better marker to identify disease progression.[3] HIV infects and destroys CD + T Lymphocytes.[4]HIVencephalopathy leads to myelin pallor leading to hyperintense signal changes as seen in T2 weighted imaging.[5] These lesions do not enhance. They do not have any mass effect. Increase in these lesions is seen as the patient condition deteriorates or CD4 or CD4% decreases. MR Spectroscopy is showing increase in choline peaks[6] and choline/creatine ratio.[78] Choline which resonates at 3.2 ppm is basically phosphatidylcholine and is a membrane constituent.[4] and is a marker of white matter lesions.[910] The study shows a correlation between CD4 count, white matter changes and choline peaks in MR Spectroscopy. Choline peaks are seen in about 89% of patients with white matter changes, which is a significant value. White matter changes are there CD4 count and CD% decreases. Significant increases in the choline/creatine ratios were seen in patients with low CD4 count.[9] The advantage of this study is that it will help in monitoring the treatment and cliniconeurological and radiological findings in HIVpatient. By having CD4 count possibility of white matter changes and its associated importance can be known.
Authors: Robin A Hurley; Thomas Ernst; Kamel Khalili; Luis Del Valle; Isabella Laura Simone; Katherine H Taber Journal: J Neuropsychiatry Clin Neurosci Date: 2003 Impact factor: 2.198
Authors: I L Simone; F Federico; C Tortorella; C F Andreula; G B Zimatore; P Giannini; G Angarano; V Lucivero; P Picciola; D Carrara; A Bellacosa; P Livrea Journal: J Neurol Neurosurg Psychiatry Date: 1998-04 Impact factor: 10.154
Authors: Robert H Paul; Constantin T Yiannoutsos; Eric N Miller; Linda Chang; Christina M Marra; Giovanni Schifitto; Thomas Ernst; Elyse Singer; Todd Richards; G Jeffrey Jarvik; Richard Price; Dieter J Meyerhoff; Dennis Kolson; Ronald J Ellis; Gilberto Gonzalez; Robert E Lenkinski; Ronald A Cohen; Bradford A Navia Journal: J Neuropsychiatry Clin Neurosci Date: 2007 Impact factor: 2.198
Authors: R Kannangai; A J Kandathil; D L Ebenezer; G Nithyanandam; P Samuel; O C Abraham; T D Sudarsanam; S A Pulimood; G Sridharan Journal: Indian J Med Microbiol Date: 2008 Jul-Sep Impact factor: 0.985
Authors: W K Chong; B Sweeney; I D Wilkinson; M Paley; M A Hall-Craggs; B E Kendall; J K Shepard; M Beecham; R F Miller; I V Weller Journal: Radiology Date: 1993-07 Impact factor: 11.105